State-Level Variation in Access to Long-Acting Injectable Antiretroviral Therapy for HIV in the United States

The article, State-Level Variation in Access to Long-Acting Injectable Antiretroviral Therapy for HIV in the United States, co-authored by NASTAD Director of Medication Access, Tim Horn, examines disparities in the availability of long-acting injectable antiretroviral therapy (LAI-ART) across different U.S. states. LAI-ART is anticipated to enhance health outcomes for individuals living with HIV. The study highlights significant variations in access to this treatment, which may contribute to unequal health outcomes among persons with HIV. Read more